# Study of PM01183 in Non-Colorectal Cancer Patients as a Days 1 and 8 Intravenous Short Infusion Every 3 Weeks

> **NCT01405391** · PHASE1 · COMPLETED · sponsor: **PharmaMar** · enrollment: 42 (actual)

## Conditions studied

- Major Advanced Solid Tumors Other Than Colorectal

## Interventions

- **DRUG:** PM01183

## Key facts

- **NCT ID:** NCT01405391
- **Lead sponsor:** PharmaMar
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11
- **Primary completion:** 2016-01
- **Final completion:** 2016-01
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2016-01-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01405391

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01405391, "Study of PM01183 in Non-Colorectal Cancer Patients as a Days 1 and 8 Intravenous Short Infusion Every 3 Weeks". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT01405391. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*